This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Fast-paced Momentum Stock Arkema (ARKAY) Is Still Trading at a Bargain
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Arkema (ARKAY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Are Investors Undervaluing Arkema (ARKAY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Arkema (ARKAY) Gets ISCC+ for Powder Coating Resins Facility
by Zacks Equity Research
The facility of Arkema (ARKAY) includes a polyester resin production line and a cutting-edge R&D laboratory dedicated to increasing the sustainability and performance of powder coating materials
Arkema (ARKAY) Unveils New Pebax Elastomer Unit in France
by Zacks Equity Research
This new facility presents a significant opportunity for Arkema (ARKAY) to meet growing demand in existing and new applications.
Arkema (ARKAY) Backs Tiamat for Lithium-Free Battery Innovation
by Zacks Equity Research
Arkema (ARKAY) invests in Tiamat, accelerating the development of lithium-free solutions and supporting the construction of a dedicated 5 GWh Giga-factory in France.
Is Arkema (ARKAY) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ARKAY vs. AVNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
ARKAY vs. AVNT: Which Stock Is the Better Value Option?
Arkema (ARKAY) to Acquire Arc Building Products in Ireland
by Zacks Equity Research
This project by Arkema (ARKAY) is scheduled to be completed in the first quarter of 2024.
Arkema (ARKAY) Finalizes 54% Stake Buy in PI Advanced Materials
by Zacks Equity Research
Arkema's (ARKAY) acquisition of a controlling stake in PI Advanced Materials will solidify its position in cutting-edge technologies for advanced electronics and electric mobility.
Arkema (ARKAY) to Expand DMDS Production Capacity in Texas
by Zacks Equity Research
Arkema (ARKAY) is investing Euro 130 million to expand its DMDS production capacity in Texas to meet the surging demand for renewable fuels.
Arkema (ARKAY) Expands Organic Peroxide Production in China
by Zacks Equity Research
Arkema (ARKAY) is investing Euro 50 million to boost organic peroxide production in China for renewable energy markets.
Arkema (ARKAY) Boosts Polymers Range With Majority Stake in PIAM
by Zacks Equity Research
Arkema (ARKAY) acquires a controlling stake in PI Advanced Materials, broadening its high-performance polymer range and transforming it into a pure specialty materials player.
Should Value Investors Buy Arkema (ARKAY) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ARKAY or AKZOY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ARKAY vs. AKZOY: Which Stock Is the Better Value Option?
Are Investors Undervaluing Arkema (ARKAY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ARKAY vs. AKZOY: Which Stock Is the Better Value Option?
by Zacks Equity Research
ARKAY vs. AKZOY: Which Stock Is the Better Value Option?
Is Arkema (ARKAY) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Arkema (ARKAY) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Linde (LIN) Beats Q4 Earnings Estimates, Hikes Capex Outlook
by Zacks Equity Research
Increased prices and volumes across all end markets aid Linde's (LIN) earnings in Q4.
Are Investors Undervaluing Arkema (ARKAY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Looking for a Growth Stock? 3 Reasons Why Arkema SA (ARKAY) is a Solid Choice
by Zacks Equity Research
Arkema SA (ARKAY) possesses solid growth attributes, which could help it handily outperform the market.
Here's Why Arkema SA (ARKAY) Looks Ripe for Bottom Fishing
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Arkema SA (ARKAY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Is Arkema (ARKAY) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Reasons Why Arkema SA (ARKAY) Is a Great Growth Stock
by Zacks Equity Research
Arkema SA (ARKAY) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Arkema SA (ARKAY) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Arkema SA (ARKAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).